| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600073 | 04286002 | WILZIN 50 mg CAPSULAS DURAS | WILZIN 50 mg CAPSULAS DURAS, 250 cápsulas | 50 mg | 6 | 250 | 43 | 250 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04286002/04286002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04286002/04286002_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2005-01-19 | 1 | 1 | 1 | 2005-01-19 | 2005-01-19 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 650320 | 04284001 | PEDEA 5 mg/ml SOLUCION INYECTABLE | PEDEA 5 mg/ml SOLUCION INYECTABLE, 4 ampollas de 2 ml | 5 mg/ml inyectable 2 ml | 1 | 4 | 1 | 4 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04284001/04284001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04284001/04284001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2004-11-18 | 1 | 1 | 1 | 2004-11-18 | 2004-11-18 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 651058 | 02246003 | CARBAGLU 200 mg COMPRIMIDOS DISPERSABLES | CARBAGLU 200 mg COMPRIMIDOS DISPERSABLES, 5 comprimidos | 200 mg | 69 | 5 | 10 | 5 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02246003/02246003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02246003/02246003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | CASEN RECORDATI S.L. | 2005-04-14 | 1 | 1 | 1 | 2005-04-14 | 2005-04-14 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 658697 | 06379001 | CYSTADANE 1 g POLVO ORAL | CYSTADANE 1 g POLVO ORAL , 1 frasco de 180 g + 3 cucharas graduadas | 1 g/g | 6 | 180 | 21 | 1 frasco de 180 g + 3 cucharas graduadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06379001/06379001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06379001/06379001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 0 | 2011-05-10 | View Edit Delete | ||||||||||||
| 661454 | 97039003 | CYSTAGON 150 mg CAPSULAS DURAS | CYSTAGON 150 mg CAPSULAS DURAS, 100 cápsulas | 150 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97039003/97039003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97039003/97039003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 661470 | 97039001 | CYSTAGON 50 mg CAPSULAS DURAS | CYSTAGON 50 mg CAPSULAS DURAS, 100 cápsulas | 50 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97039001/97039001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97039001/97039001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 663771 | 09533002 | VEDROP 50 MG/ML EN SOLUCION ORAL | VEDROP 50 MG/ML EN SOLUCION ORAL, 1 frasco de 20 ml | 50 mg/ml | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/09533002/09533002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09533002/09533002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 832998 | 02246002 | CARBAGLU 200 mg COMPRIMIDOS DISPERSABLES | CARBAGLU 200 mg COMPRIMIDOS DISPERSABLES, 60 comprimidos | 200 mg | 69 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02246002/02246002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02246002/02246002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | CASEN RECORDATI S.L. | 2003-10-28 | 1 | 1 | 1 | 2003-10-28 | 2003-10-28 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 658929 | 68732 | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68732/68732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68732/68732_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658931 | 68733 | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68733/68733_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68733/68733_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658932 | 68734 | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68734/68734_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68734/68734_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658933 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658934 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659361 | 68990 | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68990/68990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68990/68990_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659362 | 68991 | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68991/68991_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68991/68991_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659363 | 68992 | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68992/68992_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68992/68992_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659364 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659365 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 664795 | 71103 | LATANOPROST STADA 50 microgramos/ml COLIRIO EN SOLUCION | LATANOPROST STADA 50 microgramos/ml COLIRIO EN SOLUCION , 1 frasco de 2,5 ml | 50 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71103/71103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71103/71103_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2010-02-16 | 1 | 1 | 1 | 2010-02-16 | 2010-02-16 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 665891 | 10644001 | PECFENT 100 microgramos/PULVERIZACION, SOLUCION PARA PULVERIZACION NASAL | PECFENT 100 microgramos/PULVERIZACION, SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 8 dosis | 100 microgramos/dosis | 6 | 8 | 31 | 1 envase pulverizador de 8 dosis | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10644001/10644001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10644001/10644001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1236 | GRÜNENTHAL PHARMA S.A. | 2010-11-10 | 1 | 1 | 1 | 2010-11-10 | 2010-11-10 | 1 | 2011-05-12 | Lista I | View Edit Delete |
Page 50 of 1036, showing 20 records out of 20708 total, starting on record 981, ending on 1000